about
Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon VectorsInhibition of herpes simplex virus type 1 replication by adeno-associated virus rep proteins depends on their combined DNA-binding and ATPase/helicase activities.Effects of herpes simplex virus amplicon transduction on murine dendritic cells.Gene therapy in large animal models of human genetic diseases. IntroductionViral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNSGene delivery with viral vectors for cerebrovascular diseases.Design and application of oncolytic HSV vectors for glioblastoma therapy.Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type compositionRNA interference therapy for glioblastoma.Genetic therapy for the nervous system.Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indicationsFuture prospects for gene delivery systems.Rewiring brain circuits to block cataplexy in murine models of narcolepsy.Virion-associated cofactor high-mobility group DNA-binding protein-1 facilitates transposition from the herpes simplex virus/Sleeping Beauty amplicon vector platformHerpes Virus Amplicon Vectors.Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model.In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors.Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis.Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
P2860
Q27318403-3394A235-181B-4821-82CF-76B531922597Q33526941-861F5E10-C563-4487-A5FA-D416A0FE5541Q33688447-F7B946A3-DBEB-4E07-A28F-B7B455B84655Q33808511-236D2AC2-F5CC-4971-80F8-6FB4BA215EE5Q33894621-CEF1F153-61AE-4694-ABF6-4BBE0669CD01Q33917592-4DF98E1B-AADE-4AA3-9BA8-A0F7ECE197DFQ35559877-BE327F45-15AE-4134-A8AA-C69B300A24CBQ36960666-8CDFCC0C-3865-4C7E-9D28-EF818D019CFBQ36983992-3A059681-9B24-4359-A1C1-6D267DE68324Q37736499-BFAAC134-15DD-4108-AFF8-50059B412F2BQ37856565-62AE39E8-43B0-4FB6-913C-096A89AB1D96Q37895283-5518348E-F3C1-452E-AE03-B4E4000DA427Q38166648-6AA0AD3F-78F1-4DAE-BF06-94862C4090B9Q38760958-44A59BDD-2F52-472A-88E1-6D48DF30FC85Q39264695-466BE74D-C493-4634-989E-31885F2E9DB0Q39689760-35C6F04D-C42D-49EF-A087-24F295F1FE35Q39923388-3200353D-0231-4FF9-83F5-497AD948CBEAQ40126901-86170608-95C3-4413-AB8F-3B40A62F597CQ41982319-0AA9282A-AD39-46D5-8489-272A9B44BD47Q43111345-5E86043A-8CEB-409A-82F7-35CB7CD6A5A2Q45467028-05241F93-5121-4E63-A8BF-DDF239A5B312Q46684381-E77EA746-374C-4C0F-B42A-83AD82E445F2Q58779571-2C272C19-BC82-4937-8BA1-7AFD9957769F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Update on herpesvirus amplicon vectors.
@ast
Update on herpesvirus amplicon vectors.
@en
type
label
Update on herpesvirus amplicon vectors.
@ast
Update on herpesvirus amplicon vectors.
@en
prefLabel
Update on herpesvirus amplicon vectors.
@ast
Update on herpesvirus amplicon vectors.
@en
P2093
P1433
P1476
Update on herpesvirus amplicon vectors.
@en
P2093
Angelika Oehmig
Cornel Fraefel
Xandra O Breakefield
P304
P356
10.1016/J.YMTHE.2004.06.641
P577
2004-10-01T00:00:00Z